Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | CDK5 | Q00535 | 11/20 | 0.35 |
| ▸ | CDK5R1 | Q15078 | 11/20 | 0.35 |
| ▸ | VKORC1 | Q9BQB6 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6953451 | 0.99 | SMN1; SMN2 (0.39) | ABCB1POLBSMN1; SMN2L3MBTL1CDK5 | |
| SCHEMBL6954821 | 0.87 | POLB (0.38) | ABCB1POLBSMN1; SMN2L3MBTL1CDK5 | |
| SCHEMBL6955420 | 0.86 | SMN1; SMN2 (0.39) | ABCB1POLBSMN1; SMN2L3MBTL1CDK5 | |
| SCHEMBL6953834 | 0.86 | SMN1; SMN2 (0.39) | ABCB1POLBSMN1; SMN2L3MBTL1CDK5 | |
| SCHEMBL6956156 | 0.86 | SMN1; SMN2 (0.39) | ABCB1POLBSMN1; SMN2L3MBTL1CDK5 | |
| SCHEMBL6964290 | 0.86 | HTT (0.40) | SMN1; SMN2 | |
| SCHEMBL6963486 | 0.86 | ABCB1 (0.38) | ABCB1POLBSMN1; SMN2L3MBTL1CDK5 | |
| SCHEMBL6965588 | 0.85 | SMN1; SMN2 (0.40) | ABCB1POLBSMN1; SMN2L3MBTL1CDK5 | |
| SCHEMBL6953348 | 0.81 | SMN1; SMN2 (0.41) | ABCB1POLBSMN1; SMN2L3MBTL1CDK5 | |
| SCHEMBL6956690 | 0.80 | SMN1; SMN2 (0.43) | ABCB1POLBSMN1; SMN2L3MBTL1CDK5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0729465-B1 | PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS | PARKE DAVIS & CO (US) | 2003-01-22 | — | — | EP | claimed |
| EP-0729465-A1 | PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS | PARKE, DAVIS & COMPANY (US) | 1996-09-04 | — | — | EP | claimed |
| WO-1995014013-A1 | PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS | PARKE, DAVIS & COMPANY (US) | 1995-05-26 | — | — | WO | claimed |
| EP-0729465-B1 | PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS | PARKE DAVIS & CO (US) | 2003-01-22 | — | — | EP | disclosed |
| US-6005103-A | TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS | WARNER-LAMBERT COMPANY (US) | 1999-12-21 | — | — | US | disclosed |
| US-5808062-A | AIDS THERAPY | WARNER-LAMBERT COMPANY (US) | 1998-09-15 | — | — | US | disclosed |
| EP-0729465-A1 | PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS | PARKE, DAVIS & COMPANY (US) | 1996-09-04 | — | — | EP | disclosed |
| EP-0729466-A1 | PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS | PARKE, DAVIS & COMPANY (US) | 1996-09-04 | — | — | EP | disclosed |
| WO-1995014013-A1 | PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS | PARKE, DAVIS & COMPANY (US) | 1995-05-26 | — | — | WO | disclosed |
| WO-1995014014-A2 | PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS | PARKE, DAVIS & COMPANY (US) | 1995-05-26 | — | — | WO | disclosed |